Record #18290
Protein phosphatase PP5 controls bone mass and the negative effects of rosiglitazone on bone through reciprocal regulation of PPAR? (peroxisome proliferator-activated receptor ?) and RUNX2 (runt-related transcription factor 2)
Original paper date
Sep 29, 2016
Original DOI
Country
Institution
Department of Orthopaedic Surgery, Physiology and Pharmacology, University of Toledo Health Science Campus, Toledo, Ohio 43614 · Center for Diabetes and Endocrine Research, University of Toledo Health Science Campus, Toledo, Ohio 43614 · Department of Periodontics and Oral Medicine, School of Dentistry, University of Michigan, Ann Arbor, Michigan 48109
Open access
No
Article type
Citation lifecycle
How this paper is being cited
Pre-retraction
10
Same day
0
Post-retraction
13
% post-retraction
56.5%
~6.1 citations/yr before retraction · ~1.6 citations/yr after
— citing papers
Who is still citing this work
Loading…